NCT02886494 - A Study to Evaluate Efficacy and Safety of BAC in Patient With Alzheimer's Disease or Vascular Dementia | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

November 1, 2018

Study Completion Date

November 1, 2018

Conditions

Alzheimer's Disease or Vascular Dementia

Interventions

DRUG

BAC treatment

BAC, topical application on external nasal skin, scalp, and neck, 2 times daily, 30 g/day for 12 weeks

DRUG

Matched vehicle

BAC matched vehicle, topical application on external nasal skin, scalp, and neck, 2 times daily, 30 g/day for 12 weeks

Trial Locations (10)

SPRI, Brooklyn

Wake Research Associates, Raleigh

NeuroTrials Research, Inc., Atlanta

Neurology Diagnostics, Inc., Dayton

Woodland International Research Group, Little Rock

Woodland Research Northwest, LLC, Rogers

Clinical Research Consortium, Tempe

Pacific Research Network, LLC, San Diego

The Cognitive and Research Center of NJ, Springfield

Advanced Memory Research Institute of NJ, PC, Toms River